Department of Pediatrics, Cardiovascular Research Centre, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada T6G 2S2; Department of Pharmacology, Cardiovascular Research Centre, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada T6G 2S2.
Arch Biochem Biophys. 2013 Dec;540(1-2):82-93. doi: 10.1016/j.abb.2013.09.019. Epub 2013 Oct 5.
Reactive oxygen-nitrogen species play important roles in physiological and pathological processes in the heart. This review will focus on the activation of matrix metalloproteinases (MMPs) as a result of oxidative stress, and the consequences of this on heart function. Although the MMPs are considered to be secreted proteases acting on the extracellular matrix to effect tissue remodeling, it is now recognized that MMPs also rapidly act on intracellular protein targets to cause intracellular protein remodeling. Of the 23 known human MMPs, MMP-2 is widely expressed in almost all cell types, is one of the most abundant MMPs in cardiac tissue, and recent evidence has revealed mechanisms by which it is a bona fide intracellular protein. This review will discuss the intracellular localization and novel substrates of MMP-2 within the heart, how intracellular protein proteolysis leads to cardiac dysfunction, as well as the potential of MMPs inhibitors as therapy for cardiovascular diseases caused by enhanced reactive oxygen-nitrogen species.
活性氧氮物种在心脏的生理和病理过程中发挥重要作用。这篇综述将重点介绍氧化应激导致的基质金属蛋白酶(MMPs)的激活,以及这对心脏功能的影响。尽管 MMPs 被认为是分泌的蛋白酶,作用于细胞外基质以影响组织重塑,但现在人们已经认识到,MMPs 也可以快速作用于细胞内蛋白靶点,导致细胞内蛋白重塑。在 23 种已知的人类 MMPs 中,MMP-2 广泛表达于几乎所有细胞类型,是心脏组织中含量最丰富的 MMPs 之一,最近的证据揭示了其作为真正的细胞内蛋白的机制。这篇综述将讨论 MMP-2 在心脏中的细胞内定位和新的底物,细胞内蛋白水解如何导致心脏功能障碍,以及 MMPs 抑制剂作为治疗由增强的活性氧氮物种引起的心血管疾病的潜力。